1. Home
  2. AIRS vs NYXH Comparison

AIRS vs NYXH Comparison

Compare AIRS & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AirSculpt Technologies Inc.

AIRS

AirSculpt Technologies Inc.

BUY

Current Price

$1.23

Market Cap

182.4M

Sector

Health Care

ML Signal

BUY

Logo Nyxoah SA

NYXH

Nyxoah SA

BUY

Current Price

$0.85

Market Cap

137.5M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
AIRS
NYXH
Founded
2012
2009
Country
United States
Belgium
Employees
N/A
N/A
Industry
Medical/Nursing Services
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
182.4M
137.5M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
AIRS
NYXH
Price
$1.23
$0.85
Analyst Decision
Hold
Buy
Analyst Count
3
4
Target Price
★ $4.50
$4.20
AVG Volume (30 Days)
★ 853.8K
217.2K
Earning Date
11-06-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $151,818,000.00
N/A
Revenue This Year
N/A
$275.91
Revenue Next Year
$2.65
$93.27
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.15
$0.80
52 Week High
$12.00
$5.92

Technical Indicators

Market Signals
Indicator
AIRS
NYXH
Relative Strength Index (RSI) 24.35 23.47
Support Level N/A N/A
Resistance Level $3.31 $1.69
Average True Range (ATR) 0.12 0.05
MACD 0.00 -0.05
Stochastic Oscillator 8.00 5.85

Price Performance

Historical Comparison
AIRS
NYXH

About AIRS AirSculpt Technologies Inc.

AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Share on Social Networks: